Added to YB: 2025-04-15
Pitch date: 2025-04-13
BSX [neutral]
Boston Scientific Corporation
-2.45%
current return
Author Info
Disruptive Analytics has 30+ years of experience as a retail investor and is now fully engaged in managing their own money. Sign up for the newsletter.
Company Info
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide.
Market Cap
$137.2B
Pitch Price
$95.28
Price Target
N/A
Dividend
N/A
EV/EBITDA
28.67
P/E
49.51
EV/Sales
7.66
Sector
Health Care Equipment and Supplies
Category
growth
Medical Devices - Boston Scientific Corporation
BSX (overview): Leading MedTech innovator with breakthrough devices like Watchman & Farapulse. Strong 68.4% gross margin, $17B in acquisitions last decade. 2025 forecast: 12.5-14.5% revenue growth, high 20s EBIT margin. Targeting 30%+ EBIT. $138.54B market cap. No dividend. Expanding in emerging markets.
Read full article (1 min)